世界の胃腸用治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gastrointestinal Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2502 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、胃腸用治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口）、用途別市場規模（IBD、過敏性腸症候群（IBS））、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・胃腸用治療の市場動向 ・企業の競争状況、市場シェア ・胃腸用治療の種類別市場規模（経口、非経口） ・胃腸用治療の用途別市場規模（IBD、過敏性腸症候群（IBS）） ・胃腸用治療の北米市場規模2016-2027（アメリカ、カナダ） ・胃腸用治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・胃腸用治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・胃腸用治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・胃腸用治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Allergan、Johnson & Johnson、Takeda、Novartis、Pfizer、Merck、F. Hoffmann-La Roche、Eli Lilly、AstraZeneca、Procter & Gamble、Tillotts Pharma、Takeda、GlaxoSmithKline、Amgen） ・結論

Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn’s disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.

Market Analysis and Insights: Global Gastrointestinal Therapeutics Market
The global Gastrointestinal Therapeutics market size is projected to reach US$ 47920 million by 2026, from US$ 33290 million in 2019, at a CAGR of 5.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gastrointestinal Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gastrointestinal Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gastrointestinal Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gastrointestinal Therapeutics market.

Global Gastrointestinal Therapeutics Scope and Market Size
Gastrointestinal Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Parenteral

Segment by Application
IBD
Irritable Bowel Syndrome (IBS)

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Allergan
Johnson & Johnson
Takeda
Novartis
Pfizer
Merck
F. Hoffmann-La Roche
Eli Lilly
Takeda
Novartis
Tillotts Pharma
Takeda

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Parenteral
1.3 Market by Application
1.3.1 Global Gastrointestinal Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 IBD
1.3.3 Irritable Bowel Syndrome (IBS)
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gastrointestinal Therapeutics Market Perspective (2016-2027)
2.2 Gastrointestinal Therapeutics Growth Trends by Regions
2.2.1 Gastrointestinal Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gastrointestinal Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Gastrointestinal Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Gastrointestinal Therapeutics Industry Dynamic
2.3.1 Gastrointestinal Therapeutics Market Trends
2.3.2 Gastrointestinal Therapeutics Market Drivers
2.3.3 Gastrointestinal Therapeutics Market Challenges
2.3.4 Gastrointestinal Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Therapeutics Players by Revenue
3.1.1 Global Top Gastrointestinal Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Therapeutics Revenue
3.4 Global Gastrointestinal Therapeutics Market Concentration Ratio
3.4.1 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics Revenue in 2020
3.5 Gastrointestinal Therapeutics Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Therapeutics Product Solution and Service
3.7 Date of Enter into Gastrointestinal Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gastrointestinal Therapeutics Breakdown Data by Type
4.1 Global Gastrointestinal Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2022-2027)

5 Gastrointestinal Therapeutics Breakdown Data by Application
5.1 Global Gastrointestinal Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gastrointestinal Therapeutics Market Size (2016-2027)
6.2 North America Gastrointestinal Therapeutics Market Size by Type
6.2.1 North America Gastrointestinal Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Gastrointestinal Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Gastrointestinal Therapeutics Market Size by Type (2016-2027)
6.3 North America Gastrointestinal Therapeutics Market Size by Application
6.3.1 North America Gastrointestinal Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Gastrointestinal Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Gastrointestinal Therapeutics Market Size by Application (2016-2027)
6.4 North America Gastrointestinal Therapeutics Market Size by Country
6.4.1 North America Gastrointestinal Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Gastrointestinal Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Gastrointestinal Therapeutics Market Size (2016-2027)
7.2 Europe Gastrointestinal Therapeutics Market Size by Type
7.2.1 Europe Gastrointestinal Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Gastrointestinal Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Gastrointestinal Therapeutics Market Size by Type (2016-2027)
7.3 Europe Gastrointestinal Therapeutics Market Size by Application
7.3.1 Europe Gastrointestinal Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Gastrointestinal Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Gastrointestinal Therapeutics Market Size by Application (2016-2027)
7.4 Europe Gastrointestinal Therapeutics Market Size by Country
7.4.1 Europe Gastrointestinal Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Gastrointestinal Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type
8.2.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application
8.3.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region
8.4.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gastrointestinal Therapeutics Market Size (2016-2027)
9.2 Latin America Gastrointestinal Therapeutics Market Size by Type
9.2.1 Latin America Gastrointestinal Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Gastrointestinal Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Gastrointestinal Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Gastrointestinal Therapeutics Market Size by Application
9.3.1 Latin America Gastrointestinal Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Gastrointestinal Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Gastrointestinal Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Gastrointestinal Therapeutics Market Size by Country
9.4.1 Latin America Gastrointestinal Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Gastrointestinal Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type
10.2.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application
10.3.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country
10.4.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Gastrointestinal Therapeutics Introduction
11.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Gastrointestinal Therapeutics Introduction
11.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Gastrointestinal Therapeutics Introduction
11.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Gastrointestinal Therapeutics Introduction
11.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2016-2021)
11.4.5 Takeda Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Gastrointestinal Therapeutics Introduction
11.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Gastrointestinal Therapeutics Introduction
11.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Gastrointestinal Therapeutics Introduction
11.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2016-2021)
11.7.5 Merck Recent Development
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Details
11.8.2 F. Hoffmann-La Roche Business Overview
11.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Introduction
11.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2016-2021)
11.8.5 F. Hoffmann-La Roche Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Gastrointestinal Therapeutics Introduction
11.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2016-2021)
11.9.5 Eli Lilly Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Gastrointestinal Therapeutics Introduction
11.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2016-2021)
11.10.5 AstraZeneca Recent Development
11.11 Procter & Gamble
11.11.1 Procter & Gamble Company Details
11.11.2 Procter & Gamble Business Overview
11.11.3 Procter & Gamble Gastrointestinal Therapeutics Introduction
11.11.4 Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2016-2021)
11.11.5 Procter & Gamble Recent Development
11.12 Tillotts Pharma
11.12.1 Tillotts Pharma Company Details
11.12.2 Tillotts Pharma Business Overview
11.12.3 Tillotts Pharma Gastrointestinal Therapeutics Introduction
11.12.4 Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2016-2021)
11.12.5 Tillotts Pharma Recent Development
11.13 Takeda
11.13.1 Takeda Company Details
11.13.2 Takeda Business Overview
11.13.3 Takeda Gastrointestinal Therapeutics Introduction
11.13.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2016-2021)
11.13.5 Takeda Recent Development
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Details
11.14.2 GlaxoSmithKline Business Overview
11.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Introduction
11.14.4 GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2016-2021)
11.14.5 GlaxoSmithKline Recent Development
11.15 Amgen
11.15.1 Amgen Company Details
11.15.2 Amgen Business Overview
11.15.3 Amgen Gastrointestinal Therapeutics Introduction
11.15.4 Amgen Revenue in Gastrointestinal Therapeutics Business (2016-2021)
11.15.5 Amgen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gastrointestinal Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Parenteral
Table 4. Global Gastrointestinal Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Gastrointestinal Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gastrointestinal Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Gastrointestinal Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Gastrointestinal Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Gastrointestinal Therapeutics Market Share by Regions (2022-2027)
Table 10. Gastrointestinal Therapeutics Market Trends
Table 11. Gastrointestinal Therapeutics Market Drivers
Table 12. Gastrointestinal Therapeutics Market Challenges
Table 13. Gastrointestinal Therapeutics Market Restraints
Table 14. Global Gastrointestinal Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Gastrointestinal Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Therapeutics as of 2020)
Table 17. Ranking of Global Top Gastrointestinal Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Gastrointestinal Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gastrointestinal Therapeutics Product Solution and Service
Table 21. Date of Enter into Gastrointestinal Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gastrointestinal Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Gastrointestinal Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Gastrointestinal Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Gastrointestinal Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Gastrointestinal Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Gastrointestinal Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Gastrointestinal Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Gastrointestinal Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Gastrointestinal Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Gastrointestinal Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Gastrointestinal Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Gastrointestinal Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Gastrointestinal Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Gastrointestinal Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Gastrointestinal Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Gastrointestinal Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Gastrointestinal Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Gastrointestinal Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gastrointestinal Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gastrointestinal Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Gastrointestinal Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Gastrointestinal Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Gastrointestinal Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Gastrointestinal Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Gastrointestinal Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Gastrointestinal Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie Gastrointestinal Therapeutics Product
Table 64. AbbVie Revenue in Gastrointestinal Therapeutics Business (2016-2021) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Allergan Company Details
Table 67. Allergan Business Overview
Table 68. Allergan Gastrointestinal Therapeutics Product
Table 69. Allergan Revenue in Gastrointestinal Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Allergan Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Gastrointestinal Therapeutics Product
Table 74. Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Takeda Company Details
Table 77. Takeda Business Overview
Table 78. Takeda Gastrointestinal Therapeutics Product
Table 79. Takeda Revenue in Gastrointestinal Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Takeda Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Gastrointestinal Therapeutics Product
Table 84. Novartis Revenue in Gastrointestinal Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Gastrointestinal Therapeutics Product
Table 89. Pfizer Revenue in Gastrointestinal Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Pfizer Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Gastrointestinal Therapeutics Product
Table 94. Merck Revenue in Gastrointestinal Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Merck Recent Development
Table 96. F. Hoffmann-La Roche Company Details
Table 97. F. Hoffmann-La Roche Business Overview
Table 98. F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2016-2021) & (US$ Million)
Table 99. F. Hoffmann-La Roche Recent Development
Table 100. Eli Lilly Company Details
Table 101. Eli Lilly Business Overview
Table 102. Eli Lilly Gastrointestinal Therapeutics Product
Table 103. Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Eli Lilly Recent Development
Table 105. AstraZeneca Company Details
Table 106. AstraZeneca Business Overview
Table 107. AstraZeneca Gastrointestinal Therapeutics Product
Table 108. AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2016-2021) & (US$ Million)
Table 109. AstraZeneca Recent Development
Table 110. Procter & Gamble Company Details
Table 111. Procter & Gamble Business Overview
Table 112. Procter & Gamble Gastrointestinal Therapeutics Product
Table 113. Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Procter & Gamble Recent Development
Table 115. Tillotts Pharma Company Details
Table 116. Tillotts Pharma Business Overview
Table 117. Tillotts Pharma Gastrointestinal Therapeutics Product
Table 118. Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Tillotts Pharma Recent Development
Table 120. Takeda Company Details
Table 121. Takeda Business Overview
Table 122. Takeda Gastrointestinal Therapeutics Product
Table 123. Takeda Revenue in Gastrointestinal Therapeutics Business (2016-2021) & (US$ Million)
Table 124. Takeda Recent Development
Table 125. GlaxoSmithKline Company Details
Table 126. GlaxoSmithKline Business Overview
Table 127. GlaxoSmithKline Gastrointestinal Therapeutics Product
Table 128. GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2016-2021) & (US$ Million)
Table 129. GlaxoSmithKline Recent Development
Table 130. Amgen Company Details
Table 131. Amgen Business Overview
Table 132. Amgen Gastrointestinal Therapeutics Product
Table 133. Amgen Revenue in Gastrointestinal Therapeutics Business (2016-2021) & (US$ Million)
Table 134. Amgen Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Parenteral Features
Figure 4. Global Gastrointestinal Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. IBD Case Studies
Figure 6. Irritable Bowel Syndrome (IBS) Case Studies
Figure 7. Gastrointestinal Therapeutics Report Years Considered
Figure 8. Global Gastrointestinal Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Gastrointestinal Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Gastrointestinal Therapeutics Market Share by Regions: 2020 VS 2027
Figure 11. Global Gastrointestinal Therapeutics Market Share by Regions (2022-2027)
Figure 12. Global Gastrointestinal Therapeutics Market Share by Players in 2020
Figure 13. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Therapeutics as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics Revenue in 2020
Figure 15. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2016-2021)
Figure 16. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2022-2027)
Figure 17. North America Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Gastrointestinal Therapeutics Market Share by Type (2016-2027)
Figure 19. North America Gastrointestinal Therapeutics Market Share by Application (2016-2027)
Figure 20. North America Gastrointestinal Therapeutics Market Share by Country (2016-2027)
Figure 21. United States Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Gastrointestinal Therapeutics Market Share by Type (2016-2027)
Figure 25. Europe Gastrointestinal Therapeutics Market Share by Application (2016-2027)
Figure 26. Europe Gastrointestinal Therapeutics Market Share by Country (2016-2027)
Figure 27. Germany Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Gastrointestinal Therapeutics Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Gastrointestinal Therapeutics Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Gastrointestinal Therapeutics Market Share by Region (2016-2027)
Figure 37. China Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Gastrointestinal Therapeutics Market Share by Type (2016-2027)
Figure 45. Latin America Gastrointestinal Therapeutics Market Share by Application (2016-2027)
Figure 46. Latin America Gastrointestinal Therapeutics Market Share by Country (2016-2027)
Figure 47. Mexico Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Gastrointestinal Therapeutics Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Gastrointestinal Therapeutics Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Gastrointestinal Therapeutics Market Share by Country (2016-2027)
Figure 53. Turkey Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Gastrointestinal Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. AbbVie Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2021)
Figure 57. Allergan Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2021)
Figure 58. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2021)
Figure 59. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2021)
Figure 63. F. Hoffmann-La Roche Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2021)
Figure 64. Eli Lilly Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2021)
Figure 66. Procter & Gamble Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2021)
Figure 67. Tillotts Pharma Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2021)
Figure 68. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2021)
Figure 69. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2021)
Figure 70. Amgen Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---